OBJECTIVE: To assess the role of STAT4 activation in driving pathogenic follicular helper T (Tfh) cell secretion of the cytokines interleukin-21 (IL-21) and interferon-γ (IFNγ) in murine and human lupus. METHODS: The effect of STAT4-dependent Tfh cell signaling on cytokine production and autoreactive B cell maturation was assessed temporally during the course of lupus in a murine model, with further assessment of Tfh cell gene transcription performed using RNA-Seq technology. STAT4-dependent signaling and cytokine production were also determined in circulating Tfh-like cells in patients with systemic lupus erythematosus (SLE), as compared to cells from healthy control subjects, and correlations with disease activity were assessed in the Tfh-like cells from SLE patients. RESULTS: IL-21- and IFNγ-coproducing Tfh cells expanded prior to the detection of potentially pathogenic IgG2c autoantibodies in lupus-prone mice. Tfh cells transcriptionally evolved during the course of disease with acquisition of a STAT4-dependent gene signature. Maintenance of Tfh cell cytokine synthesis was dependent upon STAT4 signaling, driven by type I IFNs. Circulating Tfh-like cells from patients with SLE also secreted IL-21 and IFNγ, with STAT4 phosphorylation enhanced by IFNβ, in association with the extent of clinical disease activity. CONCLUSION: We identified a role for type I IFN signaling in driving STAT4 activation and production of IL-21 and IFNγ by Tfh cells in murine and human lupus. Enhanced STAT4 activation in Tfh cells may underlie pathogenic B cell responses in both murine and human lupus. These data indicate that STAT4 guides pathogenic cytokine and immunoglobulin production in SLE, demonstrating a potential therapeutic target to modulate autoimmunity.
OBJECTIVE: To assess the role of STAT4 activation in driving pathogenic follicular helper T (Tfh) cell secretion of the cytokines interleukin-21 (IL-21) and interferon-γ (IFNγ) in murine and human lupus. METHODS: The effect of STAT4-dependent Tfh cell signaling on cytokine production and autoreactive B cell maturation was assessed temporally during the course of lupus in a murine model, with further assessment of Tfh cell gene transcription performed using RNA-Seq technology. STAT4-dependent signaling and cytokine production were also determined in circulating Tfh-like cells in patients with systemic lupus erythematosus (SLE), as compared to cells from healthy control subjects, and correlations with disease activity were assessed in the Tfh-like cells from SLE patients. RESULTS: IL-21- and IFNγ-coproducing Tfh cells expanded prior to the detection of potentially pathogenic IgG2c autoantibodies in lupus-prone mice. Tfh cells transcriptionally evolved during the course of disease with acquisition of a STAT4-dependent gene signature. Maintenance of Tfh cell cytokine synthesis was dependent upon STAT4 signaling, driven by type I IFNs. Circulating Tfh-like cells from patients with SLE also secreted IL-21 and IFNγ, with STAT4 phosphorylation enhanced by IFNβ, in association with the extent of clinical disease activity. CONCLUSION: We identified a role for type I IFN signaling in driving STAT4 activation and production of IL-21 and IFNγ by Tfh cells in murine and human lupus. Enhanced STAT4 activation in Tfh cells may underlie pathogenic B cell responses in both murine and human lupus. These data indicate that STAT4 guides pathogenic cytokine and immunoglobulin production in SLE, demonstrating a potential therapeutic target to modulate autoimmunity.
Authors: K Miyake; H Nakashima; M Akahoshi; Y Inoue; S Nagano; Y Tanaka; K Masutani; H Hirakata; H Gondo; T Otsuka; M Harada Journal: Rheumatology (Oxford) Date: 2002-05 Impact factor: 7.580
Authors: Michelle A Linterman; Laura Beaton; Di Yu; Roybel R Ramiscal; Monika Srivastava; Jennifer J Hogan; Naresh K Verma; Mark J Smyth; Robert J Rigby; Carola G Vinuesa Journal: J Exp Med Date: 2010-02-08 Impact factor: 14.307
Authors: Melissa R Arbuckle; Micah T McClain; Mark V Rubertone; R Hal Scofield; Gregory J Dennis; Judith A James; John B Harley Journal: N Engl J Med Date: 2003-10-16 Impact factor: 91.245
Authors: Elaine F Remmers; Robert M Plenge; Annette T Lee; Robert R Graham; Geoffrey Hom; Timothy W Behrens; Paul I W de Bakker; Julie M Le; Hye-Soon Lee; Franak Batliwalla; Wentian Li; Seth L Masters; Matthew G Booty; John P Carulli; Leonid Padyukov; Lars Alfredsson; Lars Klareskog; Wei V Chen; Christopher I Amos; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Peter K Gregersen Journal: N Engl J Med Date: 2007-09-06 Impact factor: 91.245
Authors: Marta E Alarcón-Riquelme; Julie T Ziegler; Julio Molineros; Timothy D Howard; Andrés Moreno-Estrada; Elena Sánchez-Rodríguez; Hannah C Ainsworth; Patricia Ortiz-Tello; Mary E Comeau; Astrid Rasmussen; Jennifer A Kelly; Adam Adler; Eduardo M Acevedo-Vázquez; Jorge Mariano Cucho-Venegas; Ignacio García-De la Torre; Mario H Cardiel; Pedro Miranda; Luis J Catoggio; Marco Maradiaga-Ceceña; Patrick M Gaffney; Timothy J Vyse; Lindsey A Criswell; Betty P Tsao; Kathy L Sivils; Sang-Cheol Bae; Judith A James; Robert P Kimberly; Kenneth M Kaufman; John B Harley; Jorge A Esquivel-Valerio; José F Moctezuma; Mercedes A García; Guillermo A Berbotto; Alejandra M Babini; Hugo Scherbarth; Sergio Toloza; Vicente Baca; Swapan K Nath; Carlos Aguilar Salinas; Lorena Orozco; Teresa Tusié-Luna; Raphael Zidovetzki; Bernardo A Pons-Estel; Carl D Langefeld; Chaim O Jacob Journal: Arthritis Rheumatol Date: 2016-04 Impact factor: 10.995
Authors: Eric F Morand; Richard Furie; Yoshiya Tanaka; Ian N Bruce; Anca D Askanase; Christophe Richez; Sang-Cheol Bae; Philip Z Brohawn; Lilia Pineda; Anna Berglind; Raj Tummala Journal: N Engl J Med Date: 2019-12-18 Impact factor: 91.245
Authors: Niklas Hagberg; Martin Joelsson; Dag Leonard; Sarah Reid; Maija-Leena Eloranta; John Mo; Magnus K Nilsson; Ann-Christine Syvänen; Yenan T Bryceson; Lars Rönnblom Journal: Ann Rheum Dis Date: 2018-02-23 Impact factor: 19.103